Geron Corporation (GERN) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time GERN price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 56.8 Neutral
Market Cap $1.0B
Volume 16.9M
Fundamentals — 10-Q Q2 2026
Revenue $109.3M
Net Income $-20.3M
EPS $-0.03
Operating Margin -11.3%
Net Margin -18.6%
Debt / Equity 0.5x
P/E Ratio -52.3x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Lawlis V Bryan | Director | Buy | 13,300 | $1.18 | $15,694 | 2025 May 9 |
| Samuels Scott Alan | EVP, Chief Legal Officer | Buy | 15,000 | $1.61 | $24,150 | 2025 Feb 27 |
| Ziegler James | EVP, Chief Commercial Officer | Buy | 100,000 | $1.60 | $160,000 | 2025 Feb 27 |
| Scarlett John A | Chairman, President and CEO | Buy | 12,500 | $1.77 | $22,125 | 2025 Feb 27 |
| Grethlein Andrew J | EVP, Chief Operating Officer | Sell | 674,348 | $4.56 | $3.1M | 2024 Jul 8 |
| Kapur Anil | EVP, Corp Strategy & CCO | Sell | 421,875 | $4.65 | $2.0M | 2024 Jun 10 |
| Feller Faye | EVP, Chief Medical Officer | Sell | 287,900 | $4.63 | $1.3M | 2024 Jun 10 |
| Scarlett John A | Chairman, President and CEO | Sell | 600,000 | $4.00 | $2.4M | 2024 Jun 4 |
| Lawlis V Bryan | Director | Sell | 35,000 | $3.75 | $131,250 | 2024 May 15 |
| O'Farrell Elizabeth G. | Director | Buy | 13,186 | $2.28 | $30,064 | 2023 Aug 24 |
| Lawlis V Bryan | Director | Sell | 35,000 | $3.00 | $105,000 | 2023 May 11 |
| Molineaux Susan | Director | Sell | 35,000 | $2.48 | $86,800 | 2023 May 1 |
| Scarlett John A | Chairman, President and CEO | Sell | 1,340,000 | $3.04 | $4.1M | 2023 Feb 10 |
| Grethlein Andrew J | EVP, Chief Operating Officer | Sell | 384,719 | $3.03 | $1.2M | 2023 Feb 9 |
| Bloom Olivia Kyusuk | EVP, Chief Financial Officer | Sell | 400,000 | $3.08 | $1.2M | 2023 Feb 8 |
| O'Farrell Elizabeth G. | Director | Buy | 17,441 | $1.73 | $30,173 | 2020 Aug 21 |
| O'Farrell Elizabeth G. | Director | Buy | 3,000 | $1.34 | $4,028 | 2020 Jan 10 |
| Behrs Melissa Kelly | EVP, Chief Business Officer | Sell | 120,635 | $2.00 | $241,270 | 2019 Apr 9 |
| Spiegel Robert J. | Director | Sell | 175,000 | $6.85 | $1.2M | 2018 Sep 13 |
| Rosenfield Stephen | EVP, Genl Counsel & Secretary | Sell | 1,362,250 | $4.51 | $6.1M | 2018 Aug 24 |
Take GERN further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put GERN in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Geron Corporation next reports.
Set alerts on GERN
Get notified when Geron Corporation hits your price targets or technical conditions are met.
Get Started Free